NCT00002321View on ClinicalTrials.gov

A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Aldesleukin

Trial Locations (1)

43699

Med College of Ohio, Toledo

Sponsors

Lead Sponsor

Chiron Corporation
All Listed Sponsors
lead

Chiron Corporation

INDUSTRY